Japan approves AstraZeneca’s Calquence for adult patients with treatment-naïve CLL
Calquence was previously approved in Japan for the treatment of adults with relapsed or refractory Chronic Lymphocytic Leukaemia…
Recover your password.
A password will be e-mailed to you.